![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1258595-14-0
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | LHC-165 REF: 3D-IAC59514CAS: 1258595-14-0 | Min. 95% | A consultar | Lun 14 Abr 25 |
![]() | LHC-165 REF: TM-T15751CAS: 1258595-14-0 | 98% | 614,00 €~3.695,00 € | Lun 02 Jun 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
LHC-165
CAS:1258595-14-0
LHC-165 is a biodegradable polymer drug that targets the tumor microenvironment. LHC-165 has been shown …
Fórmula:
C29H32F2N3O7P
Pureza:
Min. 95%
Peso molecular:
603.55 g/mol
Ref: 3D-IAC59514
5mg | 1.434,00 € | ||
10mg | 2.293,00 € | ||
25mg | 4.300,00 € | ||
50mg | 6.879,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
LHC-165
CAS:1258595-14-0
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
Fórmula:
C29H32F2N3O7P
Pureza:
98%
Forma y color:
Solid
Peso molecular:
603.55
Ref: TM-T15751
25mg | 1.872,00 € | ||
50mg | 2.442,00 € | ||
100mg | 3.695,00 € |
Entrega estimada en Estados Unidos, el Lunes 2 de Junio de 2025